MedTrace Logo

Radiofrequency Ablation (RFA) in Breast Tumors

NCT04389216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-09-15

No results posted yet for this study

Summary

To validate the efficacy and safety of the cool-tip ablation method for breast tumors smaller than 2 cm.

Conditions

  • Breast Cancer Female

Interventions

DEVICE

Cool-tip electrode for Radiofrequency Ablation

Radiofrequency ablation of the tumour in the surgery group, associated whith axillary surgery when applicable

Sponsors & Collaborators

  • Hospital Universitari de Bellvitge

    lead OTHER

Principal Investigators

  • Amparo Garcia-Tejedor, MDPhD · Hospital Universitari Bellvitge

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2025-09-09
Completion
2025-09-09
FDA Device
Yes

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389216 on ClinicalTrials.gov